Aakaar Medical Technologies
Key Fundamentals
SMEPersonal ProductsFMCGPrice-based figures as of · TTM
- ROCE
- 18.50%
- Debt to Equity
- 0.34
- EPS (TTM)
- —
- Book Value
- ₹38.49
- Market Cap
- —
- P/E (TTM)
- —
- P/B
- 1.84
- ROE
- 17.10%
- Dividend Yield
- 0.00%
- EBITDA
- ₹11.10 Cr
- 52W High
- ₹89.95
- 52W Low
- ₹46.00
- Day Range
- ₹68.45 – ₹73.00
- Volume
- 9,600
Peer Comparison
Fast Moving Consumer Goods › Consumer Goods › Personal Care
| ₹849.00 | 45.38 | ₹86,648 Cr | 6.89 | 1.82% | 16.10% | 18.80% | ₹15,949 Cr | ₹1,914 Cr | |
| ₹395.00 | 35.52 | ₹69,681 Cr | 6.14 | 2.16% | 17.00% | 20.30% | ₹13,552 Cr | ₹1,947 Cr | |
| ₹1,660.70 | 33.17 | ₹45,422 Cr | 27.92 | 1.47% | 82.70% | 108.00% | ₹6,391 Cr | ₹1,362 Cr | |
| ₹336.50 | 329.90 | ₹44,683 Cr | 100.45 | 1.48% | 27.60% | 33.90% | ₹484 Cr | ₹137 Cr | |
| ₹7,527.00 | 36.71 | ₹23,745 Cr | 25.92 | 3.32% | 66.50% | 90.70% | ₹3,176 Cr | ₹668 Cr | |
| ₹6,959.00 | 28.57 | ₹22,555 Cr | 29.98 | 3.61% | 115.00% | 157.00% | ₹4,245 Cr | ₹790 Cr | |
| ₹381.35 | 22.24 | ₹16,773 Cr | 5.69 | 2.62% | 26.20% | 28.10% | ₹3,915 Cr | ₹749 Cr | |
| Aakaar Medical Technologies (this company) | ₹70.90 | — | ₹102 Cr | 1.84 | 0.00% | 17.10% | 18.50% | — | — |
| Median 8 companies | ₹622.00 | 35.52 | ₹34,214 Cr | 16.41 | 1.99% | 26.90% | 31.00% | ₹4,245 Cr | ₹790 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 84/100
Category scores
- Quality
- 69
- Strong
- Returns, margins, earnings quality 22% weight
- Valuation
- 37
- Weak
- Cheap vs sector & own history 24% weight
- Growth
- 50
- Average
- Sales & profit trajectory 9% weight
- Financial Health
- 72
- Strong
- Solvency, leverage, coverage 9% weight
- Momentum
- 90
- Strong
- Trend strength, vol-adjusted 12% weight
- Ownership
- 38
- Weak
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
1- Company has delivered good profit growth of 65.2% CAGR over last 5 years
Weaknesses
3- Though the company is reporting repeated profits, it is not paying out dividend
- Company has high debtors of 203 days.
- Working capital days have increased from 130 days to 199 days
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bullish | 1 | 7 | 11 |
| Oscillators | Neutral | 1 | 7 | 1 |
| Moving Averages | Strong Bullish | 0 | 0 | 10 |
Oscillators
Neutral
Overall
Strong Bullish
Moving Averages
Strong Bullish
Key readings
- RSI (14)
- 57.22
- Neutral
- MACD (12,26,9)
- 1.18
- Bullish
- SMA (50)
- 65.10
- Bullish
- SMA (200)
- 63.77
- Bullish
As of
Growth Rate
From the financial statements below. 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025.
Revenue
| 5Y | +40.02% |
|---|---|
| 3Y | +26.88% |
| 1Y | +8.74% |
Net profit
| 5Y | +65.18% |
|---|---|
| 3Y | +45.63% |
| 1Y | +10.12% |
Operating cash flow
| 5Y | Turned negative |
|---|---|
| 3Y | Outflow widened by ₹5.43 Cr |
| 1Y | Outflow widened by ₹2.95 Cr |
Operating margin· change in pp
| 5Y | +8.18 pp |
|---|---|
| 3Y | +4.64 pp |
| 1Y | −0.46 pp |
Trailing twelve months: Results are not reported for each of the last eight quarters, so there is no trailing-twelve-month figure.
Revenue by year
| Mar 2020 | ₹22.89 Cr |
|---|---|
| Mar 2021 | ₹12.44 Cr |
| Mar 2022 | ₹19.47 Cr |
| Mar 2023 | ₹32.78 Cr |
| Mar 2024 | ₹46.11 Cr |
| Mar 2025 | ₹61.58 Cr |
| Mar 2026 | ₹66.96 Cr |
Net profit by year
| Mar 2020 | ₹1.83 Cr |
|---|---|
| Mar 2021 | ₹0.54 Cr |
| Mar 2022 | ₹1.62 Cr |
| Mar 2023 | ₹2.15 Cr |
| Mar 2024 | ₹2.87 Cr |
| Mar 2025 | ₹6.03 Cr |
| Mar 2026 | ₹6.64 Cr |
Half-yearly Results
₹ Cr| Particulars | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|
| Sales | 33.88 | 25.32 | 41.64 |
| Expenses | 25.53 | 25.55 | 31.22 |
| Operating Profit | 8.35 | −0.23 | 10.42 |
| OPM % | 24.65% | −0.91% | 25.02% |
| Other Income | 0.11 | 0.3 | 0.63 |
| Interest | 0.91 | 1.04 | 0.76 |
| Depreciation | 0.07 | 0.05 | 0.08 |
| PBT | 7.48 | −1.02 | 10.21 |
| Tax % | 25.53% | −23.53% | 27.33% |
| Net Profit | 5.57 | −0.78 | 7.42 |
| EPS (₹) | 5.34 | −0.55 | 5.24 |
Profit & Loss
₹ Cr| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Sales | 22.89 | 12.44 | 19.47 | 32.78 | 46.11 | 61.58 | 66.96 |
| Expenses | 20.01 | 11.54 | 17.07 | 29.25 | 41.11 | 51.81 | 56.64 |
| Operating Profit | 2.88 | 0.9 | 2.4 | 3.53 | 5 | 9.77 | 10.32 |
| OPM % | 12.58% | 7.23% | 12.33% | 10.77% | 10.84% | 15.87% | 15.41% |
| Other Income | 0.12 | 0.12 | 0.04 | 0.09 | 0.16 | 0.18 | 0.8 |
| Interest | 0.46 | 0.23 | 0.21 | 0.43 | 1.14 | 1.71 | 1.8 |
| Depreciation | 0.04 | 0.03 | 0.02 | 0.09 | 0.14 | 0.12 | 0.13 |
| PBT | 2.5 | 0.76 | 2.21 | 3.1 | 3.88 | 8.12 | 9.19 |
| Tax % | 26.8% | 28.95% | 26.24% | 30.65% | 26.29% | 25.62% | 27.86% |
| Net Profit | 1.83 | 0.54 | 1.62 | 2.15 | 2.87 | 6.03 | 6.64 |
| EPS (₹) | 2.01 | 0.59 | 1.78 | 2.36 | 3.15 | 5.79 | 4.69 |
| Div. Payout % | 0% | 0% | 34.57% | 24.42% | 0% | 0% | 0% |
Balance Sheet
₹ Cr| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Equity Capital | 0.1 | 0.1 | 0.7 | 0.7 | 0.7 | 10.42 | 14.17 |
| Reserves | 6.75 | 7.3 | 7.33 | 8.96 | 11.84 | 12.84 | 40.38 |
| Borrowings | 5.88 | 3.88 | 3.82 | 5.87 | 15.05 | 22.74 | 18.53 |
| Other Liabilities | 3.56 | 3.03 | 6.15 | 7.7 | 6.42 | 8.16 | 6.34 |
| Total Liabilities | 16.29 | 14.31 | 18 | 23.23 | 34.01 | 54.16 | 79.42 |
| Fixed Assets | 0.06 | 0.04 | 0.2 | 0.36 | 0.28 | 0.24 | 0.29 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0.4 |
| Investments | 0.47 | 0.11 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 15.76 | 14.16 | 17.8 | 22.87 | 33.73 | 53.92 | 78.73 |
| Total Assets | 16.29 | 14.31 | 18 | 23.23 | 34.01 | 54.16 | 79.42 |
Cash Flow
₹ Cr| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Operating | −0.38 | 4.31 | 0.48 | −2.93 | −8.04 | −5.41 | −8.36 |
| Investing | 0.1 | 0.37 | −0.23 | −0.32 | −0.04 | −0.05 | 0.05 |
| Financing | 0.28 | −2 | −0.81 | 1.17 | 8.19 | 10.71 | 18.8 |
| Net Cash Flow | 0 | 2.68 | −0.55 | −2.08 | 0.11 | 5.25 | 10.48 |
| Free Cash Flow | −0.4 | 4.3 | 0.29 | −3.19 | −8.09 | −5.49 | −8.94 |
| CFO/EBITDA | 10 | 503 | 47 | −54 | −136 | −35 | −59 |
Ratios
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 118 | 136 | 104 | 114 | 129 | 166 | 203 |
| Inventory Days | 234 | 366 | 282 | 274 | 247 | 202 | 256 |
| Days Payable | 28.2 | 98.96 | 65.19 | 61.56 | 31.74 | 48.84 | 24.33 |
| Cash Conversion Cycle | 324 | 403 | 321 | 326 | 344 | 320 | 434 |
| Working Capital Days | 189 | 238 | 105 | 102 | 93.96 | 96.79 | 199 |
| ROCE % | — | 8.25% | 20.93% | 25.79% | 23.28% | 26.72% | 18.46% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Aakaar Medical Technologies insights
54 extracted metrics across FY17–FY26.
Documents
- Concall · Jun 2026PPT
- Concall · May 2026Transcript PPT Recording
- Concall · Nov 2025Transcript PPT
- 24 Sep 2026
Frequently Asked Questions about Aakaar Medical Technologies
What does Aakaar Medical Technologies Ltd do?
Where is Aakaar Medical Technologies Ltd (AAKAAR) listed?
Which sector does Aakaar Medical Technologies Ltd belong to?
What is the 52-week high and low of Aakaar Medical Technologies Ltd?
What is the Return on Equity (ROE) of Aakaar Medical Technologies Ltd?
Company Information
Incorporated in June 2013, Aakaar Medical Technologies Limited is an aesthetic medical company that offers a diverse selection of specialized cosmetic products and devices.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/AAKAAR.md for Aakaar Medical Technologies Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.